Effect of verapamil on subclinical brain damage in hypertensive patients
https://doi.org/10.29001/2073-8552-2014-29-1-34-38
Abstract
The aim of this study was to evaluate the effects of the antihypertensive treatment with verapamil on the development of brain damage in hypertensive patients. We studied 26 hypertensive stroke-free patients. Following parameters were estimated: 24-hours BP monitoring, plasma levels of the lipids and basal postprandial glucose, and brain MRI. All the parameters were evaluated before and after 6-month therapy with verapamil. Our data demonstrated that antihypertensive therapy with verapamil in hypertensive patients significantly decreased BP, had good tolerability profile, and was accompanied by the reversal of the preclinical MRI signs indicative of structural brain damage, in particular, our data showed subsidence of hydrocephalus and decrease in the periventricular and subcortical edema that depended on the antihypertensive efficacy.
About the Authors
A. Yu. Falkovskaya
Federal State Budgetary Institution "Research Institute for Cardiology" of Siberian Branch under the Russian Academy of Medical Sciences
Russian Federation
Russian Federation
V. F. Mordovin
Federal State Budgetary Institution "Research Institute for Cardiology" of Siberian Branch under the Russian Academy of Medical Sciences
Russian Federation
Russian Federation
W. Yu. Ussov
Federal State Budgetary Institution "Research Institute for Cardiology" of Siberian Branch under the Russian Academy of Medical Sciences
Russian Federation
Russian Federation
References
1. Мордовин В.Ф., Фальковская А.Ю., Белокопытова Н.В. и др. Возможности бета-блокаторов в коррекции цереброваскулярной патологии у больных артериальной гипертензией, ассоциированной с сахарным диабетом 2-го типа // Сибирский медицинский журнал (Томск). - 2009. - Т. 24. № 4, вып. 1. - С. 38-44.
2. Bolt G.R., Saxena P.R. Acute systemic and regional hemodynamic effects of felodipine, a new calcium antagonist, in conscious renal hypertensive rabbits // J. Cardiovasc. Pharmacol. - 1984. - Vol. 6(4) - Р. 707-712.
3. Elger B., Seega J., Raschack M. Oedema reduction by levemopamil in focal cerebral ischaemia of spontaneously hypertensive rats studied by magnetic resonance imaging // Eur. J. Pharmacol. - 1994. - Vol. 254(1-2). - Р. 65-71.
4. Fournier A., Messerli F.H., Achard J.M. Cerebroprotection mediated by angiotensin II a hypothesis supported by recent randomized clinical trials // J. Am. Coll. Cardiol. - 2004. -Vol. 43. - Р. 1343-1347.
5. Ginsberg M.D., Morikawa B., Lin E. Calcium antagonists in the treatment of experimental cerebral ischemia // Arzneimittelforschung. - 1991. - Vol. 41(3A). - Р. 334-337.
6. Grabowski M., Johansson B.B. Nifedipine and nimodipine: effect on blood pressure and regional cerebral blood flow in conscious normotensive and hypertensive rats // J. Cardiovasc. Pharmacol. - 1985. - Vol. 7(6). - Р. 1127-1133.
7. Law M.R., Morris J.K., Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies // Cite this as: BMJ 2009; 338: b1665 doi:10.1136/bmj.b1665
8. Morikawa E., Ginsberg M.D., Dietrich W.D. et al. Postischemic (S)-emopamil therapy ameliorates focal ischemic brain injury in rats // Stroke. - 1991. - Vol. 22(3). - Р. 355-360.
9. Oka M., Itoh Y., Wada M. et al. A comparison of Ca2+ channel blocking mode between gabapentin and verapamil: implication for protection against hypoxic injury in rat cerebrocortical slices // Br. J. Pharmacol. - 2003. - Vol. 139(2). - Р. 435-443.
10. Okaa M., Itohb Y., Fujita T. et al. Halothane attenuates the cerebroprotective action of several Na+ and Ca2+ channel blockers via reversal of their ion channel blockade // Eur. J. Pharmacol. - 2002. - Vol. 452(2). - Р. 175-181.
11. Zwieten van P.A. Protective effects of calcium antagonists in different organs and tissues // American Heart Journal. - 1993. - Vol. 125, issue 2, part 2. - Р. 566-571.
12. Staessen J., Li Y., Thijs L. et al. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials // Hypertens. Res. - 2005. -Vol. 28(5). - Р. 385-407.
13. Thoren P., Westling H., Skarphedinsson J.O. Effect of the calcium antagonists felodipine and nimodipine on cortical blood flow in the spontaneously hypertensive rat // J. Hypertens. Suppl. -1989. - Vol. 7(4). - Р. S153-S158.
14. Ueda T., Yamamoto Y.L., Diksic M. Transvenous perfusion of the brain with verapamil during focal cerebral ischemia in rats // Stroke. - 1989. - Vol. 20 - Р. 501-506.
Review
For citations:
Falkovskaya A.Yu., Mordovin V.F., Ussov W.Yu. Effect of verapamil on subclinical brain damage in hypertensive patients. Siberian Journal of Clinical and Experimental Medicine. 2014;29(1):34-38. (In Russ.) https://doi.org/10.29001/2073-8552-2014-29-1-34-38
Views:
320
.png)
Email this article 